Prospective, double-blind, placebo-controlled randomized trial of cimetidine in gastric cancer

Cimetidine is thought to inhibit suppressor T-lymphocyte function and preliminary evidence from a randomized trial indicated that it might prolong survival for patients with operable and inoperable gastric cancer. The British Stomach Cancer Group conducted a randomized, double-blind, placebo-control...

Descripción completa

Detalles Bibliográficos
Autores principales: Langman, M J S, Dunn, J A, Whiting, J L, Burton, A, Hallissey, M T, Fielding, J W L, Kerr, D J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362962/
https://www.ncbi.nlm.nih.gov/pubmed/10604733
http://dx.doi.org/10.1038/sj.bjc.6690457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362962/
https://www.ncbi.nlm.nih.gov/pubmed/10604733
http://dx.doi.org/10.1038/sj.bjc.6690457

Ejemplares similares